603259.SH
XD药明康
SSE · Healthcare · Medical - Diagnostics & Research · CN
CNY 155.84
−4.31%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
20.6x
EV/EBITDA
16.2x
Market Cap
CNY 464.99B
MomentumView details →
1D Return
−4.31%
YTD Return
+72.80%
RSI (14)
56.1
ValuationView details →
P/E (Fwd)
20.6x
EV/EBITDA
16.2x
Market Cap
CNY 464.99B
RSI (14)
56.1
MomentumView details →
1D Return
−4.31%
YTD Return
+72.80%
Similar companies
Latest newsMore news →
JPMorgan reduced its long position in WuXi AppTec H-shares from 10.54% to 10.27% on August 28, 2026, as disclosed by the Hong Kong Stock Exchange.1d agoWuXi AppTec converted its zero-coupon convertible bonds due 2027 into 7,166,606 new H shares on September 3, 2026.1d agoWuXi AppTec issued 13,631,632 H shares on August 28, 2026 due to conversion of its zero-coupon convertible bonds due 2027, increasing its H-share count.2d ago